FDA grants BTD for Venclexta in combination with azacitidine to treat patients with myelodysplastic syndromes Read more
300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData Read more
Successive drug launches will drive growth of NASH market in seven major markets: GlobalData Read more
Genentech announces full FDA approval for Venclexta combinations for acute myeloid leukaemia Read more
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData Read more
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment Read more